MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Income Statement
NASDAQ:MREO - US5894921072 - ADR
1.7 USD
+0.05 (+3.03%)
1.75 USD
+0.05 (+2.94%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 500.00K | 0.00 | 10.00M | 0.00 | 50.14M | |||
| Cost Of Goods | N/A | 0.00 | 2.57M | -1.15M | 24.63M | |||
| Gross Profit | N/A | 0.00 | 7.43M | 1.15M | 25.52M | |||
| Operating Expenses | 46.52M | 47.36M | 35.84M | 54.83M | 54.30M | |||
| Research and Development | N/A | 20.93M | 17.42M | 30.75M | 32.40M | |||
| Selling, General, and Administrative Expenses | 25.42M | 26.43M | 18.42M | 24.08M | 21.91M | |||
| Operating Income | -45.65M | -47.36M | -28.42M | -53.68M | -28.79M | |||
| Interest Income/Expense | N/A | 2.46M | -2.85M | 8.82M | 48.55M | |||
| Other Income/Expense | -6.20M | 1.65M | 1.27M | 393.00K | -338.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -50.05M | -43.25M | -30.00M | -44.47M | 19.58M | |||
| Income Tax | 0.00 | 0.00 | -532.00K | -2.34M | 2.08M | |||
| Net Income | -50.05M | -43.25M | -29.47M | -42.13M | 17.50M | |||
| EBITDA | -45.01M | -46.28M | -27.36M | -52.78M | -27.91M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.35 | -0.30 | -0.20 | -0.35 | 0.15 | |||
| Non GAAP EPS | -0.33 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | 74.26% | N/A | 50.89% | |||
| Profit Margin | -10009.40% | N/A | -294.66% | N/A | 34.90% | |||
| Operating Profit Margin | -9129.60% | N/A | -284.16% | N/A | -57.42% | |||
All data in USD